SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH H impact

Humacyte V007 Phase 3 dialysis access trial results published

Humacyte (HUMA) announces that its V007 Phase 3 hemodialysis access trial results have been published in Lancet Digital Health.

HUMA

Story updates

12:01:59 PM UTC
SquawkNews
HUMA Humacyte announces lancet digital health publication of v007 phase 3 hemodialysis access trial results

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.